Aniracetam
Aniracetam is a fat-soluble racetam that modulates AMPA receptors & has anxiolytic properties, potentially enhancing creativity, mood, & memory, particularly under stress.
Evidence last reviewed: 05 Apr 2026
- •pregnant or breastfeeding individuals
- •those with severe cognitive impairment
- •people taking certain psychiatric medications
Aniracetam has shown moderate efficacy in improving cognitive function in elderly patients with mild cognitive impairment, but results are less consistent in other populations. The evidence base includes both positive and negative findings, highlighting the need for further research.
cognitive-functionpatients with senile dementia of Alzheimer type · RCTLow
Aniracetam was part of a symptomatic treatment that showed efficacy in improving cognitive dysfunction.
pharmacokineticshealthy Chinese male volunteers · CohortModerate
The pharmacokinetics of aniracetam showed a Tmax of 0.4 hours & a Cmax of approximately 8.7 ng/mL.
cognitive-functionsubjects with chronic psychosyndrome after long-term exposure to organic solvents · RCTLow
No significant changes in neuropsychological symptoms were observed with aniracetam treatment.
cognitive-functionelderly patients with mild to moderate cognitive impairment · RCTModerate
Aniracetam showed significant improvement in psychobehavioural parameters compared to placebo.
Cognitive & Mood Support
Aniracetam & bacopa monnieri are combined to support cognitive function & enhance mood. Aniracetam is known for its anxiolytic & cognitive-enhancing effects, while bacopa monnieri supports memory & reduces anxiety.
Forms & usage▾
Typical doses range from 750 to 1500 mg daily, taken with meals for better absorption.